The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: A UK study
- 1 December 2001
- journal article
- Published by Elsevier in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
- Vol. 92 (6) , 623-628
- https://doi.org/10.1067/moe.2001.118902
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Progress and Problems in the Fight against AIDSNew England Journal of Medicine, 1998
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- British HIV Association guidelines for antiretroviral treatment of HIV seropositive individualsThe Lancet, 1997
- HIV-1 Protease InhibitorsJAMA, 1997
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individualsThe Lancet, 1996
- Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infectionThe Lancet, 1994
- Immediate versus deferred zidovudineThe Lancet, 1993
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987